These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 23385241)

  • 61. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction.
    Balamurugan R; Balaji V; Ramakrishna BS
    Indian J Med Res; 2008 May; 127(5):472-7. PubMed ID: 18653911
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
    Nishikawa J; Kudo T; Sakata S; Benno Y; Sugiyama T
    Scand J Gastroenterol; 2009; 44(2):180-6. PubMed ID: 18825588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC).
    Li W; Sun Y; Dai L; Chen H; Yi B; Niu J; Wang L; Zhang F; Luo J; Wang K; Guo R; Li L; Zou Q; Ma ZS; Miao Y
    BMC Microbiol; 2021 May; 21(1):138. PubMed ID: 33947329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.
    Schirmer M; Denson L; Vlamakis H; Franzosa EA; Thomas S; Gotman NM; Rufo P; Baker SS; Sauer C; Markowitz J; Pfefferkorn M; Oliva-Hemker M; Rosh J; Otley A; Boyle B; Mack D; Baldassano R; Keljo D; LeLeiko N; Heyman M; Griffiths A; Patel AS; Noe J; Kugathasan S; Walters T; Huttenhower C; Hyams J; Xavier RJ
    Cell Host Microbe; 2018 Oct; 24(4):600-610.e4. PubMed ID: 30308161
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission.
    Li Z; Li Z; Zhu L; Dai N; Sun G; Peng L; Wang X; Yang Y
    Front Nutr; 2021; 8():778542. PubMed ID: 35028306
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus.
    Vigsnaes LK; van den Abbeele P; Sulek K; Frandsen HL; Steenholdt C; Brynskov J; Vermeiren J; van de Wiele T; Licht TR
    Sci Rep; 2013; 3():1110. PubMed ID: 23346367
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
    Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
    Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum bacterial toxins are related to the progression of inflammatory bowel disease.
    Qiu H; Sun X; Sun M; He C; Li Z; Liu Z
    Scand J Gastroenterol; 2014 Jul; 49(7):826-33. PubMed ID: 24853095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis.
    Hodgkins P; Yen L; Yarlas A; Karlstadt R; Solomon D; Kane S
    Inflamm Bowel Dis; 2013 Feb; 19(2):386-96. PubMed ID: 22648999
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.
    Fite A; Macfarlane S; Furrie E; Bahrami B; Cummings JH; Steinke DT; Macfarlane GT
    J Clin Microbiol; 2013 Mar; 51(3):849-56. PubMed ID: 23269735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
    Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
    Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
    Aggarwal S; Ahuja V; Paul J
    Dig Dis Sci; 2017 Oct; 62(10):2768-2779. PubMed ID: 28667430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
    Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
    J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice.
    Tian Y; Zuo L; Guan B; Wu H; He Y; Xu Z; Shen M; Hu J; Qian J
    Nutrition; 2022 Oct; 102():111712. PubMed ID: 35802940
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.
    Angelberger S; Reinisch W; Makristathis A; Lichtenberger C; Dejaco C; Papay P; Novacek G; Trauner M; Loy A; Berry D
    Am J Gastroenterol; 2013 Oct; 108(10):1620-30. PubMed ID: 24060759
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.
    Vrakas S; Mountzouris KC; Michalopoulos G; Karamanolis G; Papatheodoridis G; Tzathas C; Gazouli M
    PLoS One; 2017; 12(1):e0170034. PubMed ID: 28099495
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
    Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
    World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
    Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM
    Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.